 SAN DIEGO, Nov. 18, 2020 GLOBE NEWSWIRE -- Exagen Inc. Nasdaq: XGN, an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the following December investor conferences: 